Chang-Oh Chung

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease

Min Su Kang, S. Gauthier, J. Soucy, 2016, Molecular Psychiatry.

Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

S. Gauthier, P. Rosa-Neto, N. Kandiah, 2017, Neurology.

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

S. Gauthier, P. Rosa-Neto, N. Kandiah, 2017, Neurology.

Comparison of global and voxel-based diagnostic classification using [18F]florbetapir ROC estimates

Pedro Rosa-Neto, Sulantha S. Mathotaarachchi, Monica Shin, 2015, Alzheimer's & Dementia.

Should a global or a regional measure of amyloidosis be used in a longitudinal study?

V. Fonov, Maxime J Parent, P. Rosa-Neto, 2015, Alzheimer's & Dementia.